The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
T Liu, J Zhang, Y Yang, H Ma, Z Li, J Zhang… - EMBO molecular …, 2020 - embopress.org
Progression to severe disease is a difficult problem in treating coronavirus disease 2019
(COVID‐19). The purpose of this study is to explore changes in markers of severe disease in …
(COVID‐19). The purpose of this study is to explore changes in markers of severe disease in …
Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread to become a
worldwide emergency. Early identification of patients at risk of progression may facilitate …
worldwide emergency. Early identification of patients at risk of progression may facilitate …
Laboratory findings in COVID-19 diagnosis and prognosis
A Pourbagheri-Sigaroodi, D Bashash, F Fateh… - Clinica chimica acta, 2020 - Elsevier
Background Since its first description, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), formerly known as 2019-nCoV, has attracted tremendous attention in a short …
(SARS-CoV-2), formerly known as 2019-nCoV, has attracted tremendous attention in a short …
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
1. Cooksley CD, Avritscher EBC, Bekele BN, et al. Epidemiology and outcomes of serious
influenza-related infections in the cancer population. Cancer. 2005; 104: 618e628. 2 …
influenza-related infections in the cancer population. Cancer. 2005; 104: 618e628. 2 …
[HTML][HTML] The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures
In December 2019, a viral pneumonia outbreak caused by a novel betacoronavirus, the
2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the …
2019 novel coronavirus (2019-nCoV), began in Wuhan, China. We report the …
[HTML][HTML] Subunit vaccines against emerging pathogenic human coronaviruses
Seven coronaviruses (CoVs) have been isolated from humans so far. Among them, three
emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus …
emerging pathogenic CoVs, including severe acute respiratory syndrome coronavirus …
Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China
C Wu, X Chen, Y Cai, X Zhou, S Xu… - JAMA internal …, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is an emerging infectious disease that
was first reported in Wuhan, China, and has subsequently spread worldwide. Risk factors for …
was first reported in Wuhan, China, and has subsequently spread worldwide. Risk factors for …
COVID‐19 and neutrophils: the relationship between hyperinflammation and neutrophil extracellular traps
Coronavirus disease 2019 (COVID‐19) is a virus‐induced respiratory disease that may
progress to acute respiratory distress syndrome (ARDS) and is triggered by …
progress to acute respiratory distress syndrome (ARDS) and is triggered by …
Immune responses and pathogenesis of SARS‐CoV‐2 during an outbreak in Iran: comparison with SARS and MERS
M Rokni, V Ghasemi, Z Tavakoli - Reviews in medical virology, 2020 - Wiley Online Library
The beginning of 2020 has seen the emergence of COVID‐19, an outbreak caused by a
novel coronavirus, SARS‐CoV‐2, an important pathogen for humans. There is an urgent …
novel coronavirus, SARS‐CoV‐2, an important pathogen for humans. There is an urgent …
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
JJ Manson, C Crooks, M Naja, A Ledlie… - The Lancet …, 2020 - thelancet.com
Background A subset of patients with severe COVID-19 develop a hyperinflammatory
syndrome, which might contribute to morbidity and mortality. This study explores a specific …
syndrome, which might contribute to morbidity and mortality. This study explores a specific …